GNRH1 and prostate cancer: Hereby, using a nationwide database, we aimed to study whether regular aspirin use is associated with a risk reduction of major adverse cardiovascular and cerebrovascular events (MACCEs) in prostate cancer patients receiving GnRH therapy.